GSK shares jumped ... claims its Zantac heartburn drug causes cancer. The Delaware Supreme Court said it will review a decision by a lower court to let an upcoming trial hear evidence from ...
GSK plc (LSE/NYSE: GSK), a leading global pharmaceutical company, has reached a confidential settlement in a Zantac (ranitidine ... objective in the phase II trial. TD Cowen maintained a Hold ...
Delaware’s top court is set to hear an appeal from GSK and other pharmaceutical ... In December 2022, approximately 50,000 Zantac cases were dismissed during a pre-trial hearing in Florida.
Aug 27 (Reuters) - Delaware's highest court said on Tuesday it will hear an appeal by GSK (GSK.L), opens ... heartburn drug Zantac caused cancer. There has been no trial or final judgment in ...
Sept 11 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial ...
GSK Plc’s experimental vaccine for herpes failed in an early-stage trial, halting an effort to bring the first shot for the condition to market. While there were no safety concerns, the trial ...
More than 300 million people around the world suffer from COPD, with about 40% exhibiting the type of inflammation affecting patients in GSK’s latest trial, according to the company. The disease ...
GSK has announced that Part II of the Phase I/II TH HSV REC-003 trial of its therapeutic herpes simplex virus (HSV) vaccine candidate, GSK3943104, did not meet its primary efficacy endpoint.
(Sharecast News) - GSK announced promising results from its phase two clinical trial for an mRNA-based seasonal flu vaccine on Thursday. The FTSE 100 pharmaceuticals giant said the study ...
GSK plc (LSE/NYSE: LON:GSK), a leading global pharmaceutical company, has reached a confidential settlement in a Zantac (ranitidine ... to meet the primary efficacy objective in the phase II trial. TD ...
GSK’s (NYSE:GSK) investigational herpes simplex virus (HSV) vaccine candidate failed to meet the primary goal of a mid-stage trial and will not progress to a late-stage trial. The British ...
